Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16676069rdf:typepubmed:Citationlld:pubmed
pubmed-article:16676069lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C0027883lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C0160390lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C0003440lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:16676069lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:16676069pubmed:issue5lld:pubmed
pubmed-article:16676069pubmed:dateCreated2006-5-5lld:pubmed
pubmed-article:16676069pubmed:abstractTextWe recently demonstrated that antithrombin (AT) reduces ischemia/reperfusion (I/R)-induced liver injury in rats by increasing hepatic tissue levels of calcitonin gene-related peptide (CGRP), a neuropeptide released from the sensory nerve endings. In the present study, we examined the effect of AT on I/R-induced liver injury in wild type mice (CGRP+/+) and congenitally alphaCGRP-deficient mice (CGRP-/-). We also investigated any effects of AT on CGRP release from dorsal root ganglion neurons (DRG) isolated from CGRP+/+. Based on results obtained in the present study, we attempted to determine if the anti-inflammatory activity of AT in vivo is dependent mainly on sensory neuron activation. AT enhanced ischemia/reperfusion-induced increases in hepatic tissue levels of CGRP and 6-keto-PGF(1alpha), a stable metabolite of PGI2, in CGRP+/+, but it did not enhance these increases in CGRP-/-. AT inhibited reperfusion-induced increases in serum alanine aminotransferase levels by increasing hepatic tissue blood flow and by attenuating increases in hepatic levels of tumor necrosis factor and myeloperoxidase in CGRP+/+, although it showed neither of these therapeutic effects in CGRP-/-. AT increased CGRP release from cultured DRGs only in the presence of anandamide, and AT-induced increase in CGRP release was not observed in the presence KT5720, an inhibitor of protein kinase A (PKA). AT markedly increased intracellular levels of cAMP in the presence of anandamide. These results strongly suggest that AT might reduce I/R-induced liver injury by enhancing activation of the sensory neurons through activation of PKA in sensory neurons.lld:pubmed
pubmed-article:16676069pubmed:languageenglld:pubmed
pubmed-article:16676069pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16676069pubmed:citationSubsetIMlld:pubmed
pubmed-article:16676069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16676069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16676069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16676069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16676069pubmed:statusMEDLINElld:pubmed
pubmed-article:16676069pubmed:monthMaylld:pubmed
pubmed-article:16676069pubmed:issn0340-6245lld:pubmed
pubmed-article:16676069pubmed:authorpubmed-author:OkajimaKenjiKlld:pubmed
pubmed-article:16676069pubmed:authorpubmed-author:UchibaMitsuhi...lld:pubmed
pubmed-article:16676069pubmed:authorpubmed-author:HaradaNaoakiNlld:pubmed
pubmed-article:16676069pubmed:authorpubmed-author:NakagataNaomi...lld:pubmed
pubmed-article:16676069pubmed:authorpubmed-author:KuriharaHirok...lld:pubmed
pubmed-article:16676069pubmed:issnTypePrintlld:pubmed
pubmed-article:16676069pubmed:volume95lld:pubmed
pubmed-article:16676069pubmed:ownerNLMlld:pubmed
pubmed-article:16676069pubmed:authorsCompleteYlld:pubmed
pubmed-article:16676069pubmed:pagination788-95lld:pubmed
pubmed-article:16676069pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:meshHeadingpubmed-meshheading:16676069...lld:pubmed
pubmed-article:16676069pubmed:year2006lld:pubmed
pubmed-article:16676069pubmed:articleTitleAntithrombin reduces reperfusion-induced liver injury in mice by enhancing sensory neuron activation.lld:pubmed
pubmed-article:16676069pubmed:affiliationDepartment of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto, Japan.lld:pubmed
pubmed-article:16676069pubmed:publicationTypeJournal Articlelld:pubmed